3 Canadian Pot Stocks That Could Gain Momentum in August 2026
Canadian cannabis stocks are once again gaining attention as investors search for opportunities within the global marijuana industry. The sector has experienced significant changes since Canada legalized recreational cannabis in 2018. However, several leading companies have emerged stronger after years of restructuring, cost reductions, and increased competition.
More importantly, the Canadian cannabis market continues to show steady consumer demand. Recent Health Canada data shows sales volumes remain substantial across flower, extracts, edibles, and medical cannabis. Additionally, total packaged cannabis sales increased compared with the previous year.
Meanwhile, international expansion has become increasingly important for Canadian cannabis producers. Companies are targeting medical marijuana opportunities throughout Europe, Australia, and other developing markets. Consequently, international cannabis sales could become a key growth driver for Canadian operators in the coming years.
In fact, analysts have identified international growth and operational efficiency as important themes for the Canadian cannabis industry in 2026. Companies with lower production costs and stronger margins could have an advantage. Furthermore, businesses that generate positive cash flow may separate themselves from weaker competitors.
Canadian Pot Stocks to Keep on Your Radar
Several major Canadian producers are already showing signs of improving operations. Canopy Growth reported 20% growth in fiscal 2026 Canadian adult-use cannabis revenue. Its Canadian medical cannabis revenue also increased 18% during the year.
Village Farms has also delivered strong cannabis growth, particularly through international exports. Meanwhile, Tilray continues expanding its Canadian and international cannabis operations. Tilray reported 5% growth in Canadian adult-use gross revenue during fiscal 2026.
Still, marijuana stocks remain highly speculative and can experience significant price swings. Therefore, investors should carefully examine revenue growth, profitability, cash flow, and international expansion.
With that in mind, three Canadian cannabis stocks stand out heading further into August 2026. Tilray Brands (TLRY), Canopy Growth (CGC), and Village Farms International (VFF) could be important names to watch.
[Read More] Here Is How Marijuana Stocks Can Make You Money Today
3 Top Marijuana Stocks to Watch in August 2026
- Tilray Brands, Inc. (NASDAQ: TLRY)
- Canopy Growth Corporation (NASDAQ: CGC)
- Village Farms International, Inc. (NASDAQ: VFF)
Tilray Brands, Inc. (NASDAQ: TLRY)
Tilray Brands is one of the largest and most diversified cannabis companies trading on a major U.S. exchange. The company operates across cannabis, beverages, wellness products, pharmaceuticals, and hospitality. Moreover, Tilray has established operations throughout Canada, Europe, and the United States. Its cannabis portfolio includes brands such as Good Supply, Redecan, Broken Coast, and Solei. Additionally, Tilray Medical has built a growing presence within international medical cannabis markets.
In the United States, Tilray’s largest physical presence comes through its beverage and wellness businesses. Its craft beverage brands have particularly strong positions across several regional markets. However, Tilray does not currently operate traditional marijuana dispensaries in the United States. Therefore, its U.S. dispensary count remains zero. Instead, management has built infrastructure that could create opportunities if federal cannabis regulations continue to change. Tilray also operates CBD and wellness businesses within the American market. Consequently, investors often view TLRY as both a cannabis stock and a diversified consumer company.
Latest Financials
Tilray recently reported record results for its fiscal year ending May 31, 2026. Net revenue increased 11% to approximately $915.5 million. Meanwhile, gross profit increased 8% to $260.4 million. Cannabis net revenue also improved 8%, reaching approximately $268.3 million. Cannabis gross profit climbed to $107.1 million, while cannabis gross margin remained strong at 40%. Fourth-quarter net revenue also increased 25% to $281.7 million. Fourth-quarter cannabis revenue increased 5% to $71.5 million. However, Tilray still reported a fiscal-year net loss of $105.2 million. Much of that loss came from non-cash charges. Adjusted net income improved nearly 90% to $12.2 million. Additionally, adjusted EBITDA increased to $61.1 million from $55 million. Tilray finished fiscal 2026 with approximately $235 million in cash, restricted cash, and marketable securities. Looking forward, management expects fiscal 2027 adjusted EBITDA between $68 million and $75 million. Therefore, improving profitability could make TLRY interesting during August.
[Read More] Top 3 Ancillary Marijuana Stocks to Watch in August 2026
Canopy Growth Corporation (NASDAQ: CGC)
Canopy Growth remains one of the cannabis industry’s most recognized publicly traded companies. The Canadian company focuses heavily on medical and recreational cannabis products. Its portfolio includes Tweed, 7ACRES, DOJA, Deep Space, Claybourne, and MTL Cannabis. Additionally, Canopy owns Storz & Bickel, a leading premium cannabis vaporizer company. Canopy’s primary cannabis operations remain centered in Canada. However, its connection with Canopy USA provides exposure to the American marijuana market. Canopy USA owns Acreage Holdings, Wana Brands, and approximately 77% of Jetty. Acreage gives the platform a direct connection with state-legal cannabis markets.
Its main retail brand, The Botanist, operates dispensaries across five states. Those states include New York, New Jersey, Connecticut, Ohio, and Massachusetts. Currently, The Botanist’s U.S. retail footprint includes more than 11 dispensaries. Moreover, Canopy USA’s portfolio provides exposure beyond traditional retail stores. Wana provides strong edible exposure, while Jetty specializes in cannabis extracts and vaping products. Consequently, Canopy has positioned itself for future opportunities in the American cannabis market.
Latest Financials
Canopy Growth released its first-quarter fiscal 2027 financial results on August 7, 2026. Consolidated net revenue increased 13% year-over-year to C$81.2 million. Cannabis net revenue increased 14% to approximately C$65.1 million. Meanwhile, Canadian medical cannabis revenue increased 22% to C$25.8 million. Adult-use cannabis revenue grew 10% to C$29.7 million. International cannabis revenue also increased 10%, reaching approximately C$9.6 million. Adjusted gross margin also improved considerably during the quarter. Adjusted gross margin reached 31%, compared with 25% one year earlier. However, Canopy still reported an adjusted EBITDA loss of C$3.2 million. Encouragingly, that loss improved by 59% from the previous year. The company’s overall net loss also declined 68% year-over-year. Nevertheless, free cash outflow increased to C$25.7 million. Therefore, cash usage remains an important risk for investors. Still, stronger revenue and improving margins provide reasons to watch CGC closely.
[Read More] 3 Marijuana Stocks To Watch As More Changes Take Place In The Industry
Village Farms International, Inc. (NASDAQ: VFF)
Village Farms International has developed into an increasingly important global cannabis producer. The company originally built its business around large-scale controlled-environment agriculture. However, cannabis has become a major driver of its growth and profitability. Its Canadian cannabis operations primarily run through Pure Sunfarms. Pure Sunfarms operates one of the world’s largest cannabis cultivation facilities in British Columbia. Additionally, Village Farms owns Rose LifeScience and operates regulated cannabis businesses in the Netherlands. Its brands include Pure Sunfarms, Fraser Valley Weed Co., Soar, Super Toast, and Pure Laine.
In the United States, Village Farms operates CBDistillery through Balanced Health Botanicals. CBDistillery provides hemp-derived cannabinoid wellness products through e-commerce and retail distribution. However, Village Farms currently operates zero marijuana dispensaries within the United States. Instead, the company has maintained assets that could support future American cannabis expansion. Village Farms also previously retained two Texas greenhouses for potential cannabis opportunities. Therefore, changing federal and state regulations could eventually create another meaningful growth opportunity.
Latest Financials
Village Farms reported impressive second-quarter 2026 results on August 10. Consolidated net sales reached approximately $64 million. That represented 27% sequential growth and 7% year-over-year growth. More importantly, cannabis revenue reached a record $53.5 million during the quarter. International cannabis export sales also reached a record $20.9 million. Those export sales increased 74% year over year and 43% sequentially. Meanwhile, the company generated net income of approximately $7.1 million. Earnings reached $0.06 per share during the quarter.
Additionally, operating cash flow totaled approximately $8.9 million. Cannabis adjusted EBITDA from continuing operations reached a record $15.3 million. That figure represented an impressive 29% of cannabis sales. Furthermore, Village Farms ended the quarter with approximately $73 million in cash. Production efficiency also improved as its Delta facilities generated record harvest yields. Consequently, production costs declined while margins benefited from a stronger product mix. These improving fundamentals make VFF a notable marijuana stock to watch during August 2026.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
